CTSO
Cytosorbents Crp
4.20$
+7.3%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +72.3% | +43.1% | +35.1% | +78.9% | +48.9% | +13.6% | +70.9% | +0.2% | +79.1% | -13.6% | -45.4% | |
| – | -45.1% | +621.1% | +20.2% | +62.5% | -47.3% | +65.8% | +31.8% | -38.7% | -2.6% | +1.6% | -26.5% | |
| – | -77.3% | +369.8% | -29.3% | +167.3% | -52.2% | -38.8% | +339.5% | -20.2% | – | – | – | |
| – | – | – | -109.7% | – | – | – | – | -654.8% | – | -285.4% | – | |
| – | +75.2% | -7.4% | +181.8% | -9.4% | 0.0% | +10.3% | +155.4% | +50.8% | -85.5% | -69.6% | -42.3% | |
| – | -61.5% | – | -205.1% | -9.4% | 0.0% | +10.3% | +155.4% | +50.8% | -85.5% | -28.5% | -38.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -98.4% | +8,163.0% | -76.9% | -28.1% | -39.8% | -106.0% | -55.2% | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | -103.0% | – | -400.0% | – | +0.0% | -100.0% | – | -75.2% | |
| – | +16.2% | -56.5% | +297.4% | -13.2% | -53.2% | +711.3% | -98.9% | +593.5% | +191.8% | -35.5% | -0.2% | |
| – | +20.3% | -104.2% | – | -58.2% | -300.8% | – | -129.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.